Christian R. Schubert

Christian R. Schubert currently serves as Vice President and Head of AbbVie Ventures, overseeing investments in transformative scientific opportunities that align with core R&D interests. In addition, Christian holds multiple board positions, including observer roles at Umoja Biopharma and Enthera Pharmaceuticals, and membership on the boards of ReAx Biotechnologies, Portera Therapeutics, Mozart Therapeutics, DISCO Pharmaceuticals, Ribometrix Inc., and Aquinnah Pharmaceuticals. Educational background includes advanced degrees from prestigious institutions such as Harvard Medical School, the Massachusetts Institute of Technology, and the Technical University of Munich, focusing on neuroscience, biological chemistry, and biochemistry.